Gedent
An orthodontics enterprise dedicated to the R&D of advanced dental materials, AI-assisted diagnosis systems, and regenerative medical biological roots.
An orthodontics enterprise dedicated to the R&D of advanced dental materials, AI-assisted diagnosis systems, and regenerative medical biological roots.
Gedent is an orthodontics enterprise founded in 2019. The company's focus lies in the R&D of advanced dental materials, AI-assisted diagnosis systems, and regenerative medical biological roots. Their recent milestone includes a substantial $15.00M Angel Round investment on 08 June 2023, with 成都天府国际生物城投资开发有限公司 as the investing entity. Gedent's commitment to cutting-edge technology and medical innovation positions them as an intriguing prospect for venture capital firms interested in the healthcare and biotech sectors. With their emphasis on pioneering research and development, Gedent presents a strong potential for disrupting the orthodontics industry through innovation and advanced technologies. In the context of increasingly personalized healthcare and the growing demand for advanced dental solutions, Gedent's pursuit of novel approaches to orthodontic treatment holds promise for both patients and investors alike.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Angel Round | $15.00M | 1 |
|
08 Jun 2023 |
No recent news or press coverage available for Gedent.
We care about your data, and we'd love to use cookies make your experience better.
